NanoString Technologies News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

26.02.20	NanoString Technologies Releases Fourth Quarter and Full Year 2019 Operating Results and Provides 2020 Financial Outlook (Businesswire)
20.02.20	NanoString Highlights Groundbreaking Spatial Genomics Research Using Expanding Portfolio of GeoMx High-Plex RNA Atlas Products at 2020 Advances in Genome Biology and Technology (AGBT) Conference (Businesswire)
18.02.20	NanoString to Present at the 40th Annual Cowen Healthcare Conference (Businesswire)
10.02.20	NanoString to Release Fourth Quarter and Fiscal Year 2019 Financial Results and Host Conference Call on Wednesday, February 26, 2020 (Businesswire)
15.01.20	Two Landmark Nature Publications use NanoString’s GeoMx Digital Spatial Profiling to Dissect Mechanisms of Response to Immunotherapy (Businesswire)
13.01.20	NanoString Provides Preliminary Operational and Financial Results for Fourth Quarter and FY 2019 (Businesswire)
02.01.20	NanoString to Present at the 38th Annual JP Morgan Healthcare Conference (Businesswire)
11.12.19	NanoString Announces the Creation of the GeoMx Breast Cancer Consortium (Businesswire)
03.12.19	NanoString Announces Exclusive License of nCounter Diagnostic Assets and Rights to Veracyte (Businesswire)
03.12.19	Nature Medicine Publication Highlights Use of NanoString’s Hyb & Seq Technology to Perform Rapid Genotypic and Phenotypic Antibiotic Susceptibility Testing (Businesswire)
25.11.19	NanoString to Present at the Evercore ISI 2nd Annual HealthCONx Conference (Businesswire)
13.11.19	NanoString to Present at the Stifel 2019 Healthcare Conference (Businesswire)
07.11.19	NanoString Highlights the Results of Research Presented at the 2019 Annual Meeting of the Society of Immunotherapy for Cancer (SITC) (Businesswire)
04.11.19	NanoString Technologies Releases Operating Results for Third Quarter of 2019 (Businesswire)
04.11.19	NanoString Announces Availability of the GeoMx Cancer Transcriptome Atlas Through the Technology Access Program for Digital Spatial Profiling (Businesswire)
04.11.19	NanoString Technologies Supports the Human Cell Atlas (HCA) to Enable High-plex Spatial Analysis Across Discovery Programs (Businesswire)
31.10.19	NanoString Appoints Don Kania, Ph.D. to its Board of Directors (Businesswire)
07.10.19	NanoString to Release Third Quarter 2019 Financial Results and Host Conference Call on Monday, November 4, 2019 (Businesswire)
04.10.19	NanoString Reports Inducement Grant Under NASDAQ Listing Rules (Businesswire)
02.10.19	NanoString Appoints Mark Winham Senior Vice President of Operations (Businesswire)
23.09.19	NanoString Introduces New Gene Expression Research Panel for Human Organ Transplantation (Businesswire)
10.01.19	5 Top Gainers In Healthcare Sector (ATOS, AZRX, NSTG...) (RTTNews)
23.05.18	FWP Back In News, ARCT Gearing Up For The Big Day, All Eyes On QTNT (RTTNews)
11.04.18	AGTC Awaits Gene Therapy Data, FDA Delays Decision On Elagolix, KPTI On Watch (RTTNews)
29.08.17	Bayer announces enrollment of first U.S. patient in Phase III trials of vilaprisan in uterine fibroids (PR Newswire)
11.01.17	Gainers & Losers Of The Day: BIOC, CUR, ONTX, EGLT, ABAX... (RTTNews)
10.01.16	NanoString Sees Q4 Revenue Growth Of 35% To 42% (RTTNews)
28.05.15	Merck, NanoString Collaborate To Develop Immune-Related Gene Expression Assay (RTTNews)
18.03.15	Prosigna, der Brustkrebstest von NanoString Technologies, wurde in die deutsche Leitlinie zur Behandlung von Brustkrebs aufgenommen (GlobeNewswire)
09.01.15	NanoString Sees Q4 Revenue Of $15.0 Mln To $16.0 Mln, Ups Full Year View (RTTNews)
01.10.13	NanoString, Fluidigm To Settle Lawsuits In U.S And Singapore - Quick Facts (RTTNews)
11.09.13	FOLD Cuts A Deal, SNTA On Watch, NanoString Makes Mega Leap, GALT Vaults (RTTNews)
09.09.13	NanoString Receives FDA Clearance For Prosigna Breast Cancer Assay (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	74.30	1.53 %	K V
Holcim	87.38	1.49 %	K V
Roche Hldg G	251.00	1.46 %	K V
Swiss Re	130.35	1.44 %	K V
UBS Group	27.07	1.35 %	K V
Swisscom	501.00	0.52 %	K V
Lonza Grp	532.40	0.26 %	K V
Nestle	74.08	0.14 %	K V
Sonova Hldg	295.60	0.00 %	K V
Geberit	512.20	-0.39 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu NanoString Technologies Inc

Aktien Top/Flop

Meistgelesene Nachrichten